|
 |
|
Andrew J Holman MD, Chief Science Officer Dr. Holman has practiced rheumatology in Renton, Washington for thirteen years and is also Clinical Assistant Professor of Medicine at the University of Washington. Originally from Seattle, he graduated from Bowdoin College with Honors in 1981, and from the University of Missouri-Columbia School of Medicine in 1987. He completed his Internal Medicine residency in 1990 at Presbyterian-Denver Hospital in Denver, Colorado and his rheumatology fellowship at the University of Washington in 1992. He has been Board Certified in internal medicine (1990-2000) and rheumatology (1992-2013) and has a special interest in new treatment options for Fibromyalgia and complex inflammatory arthritis. He is a member of the Advisory Board of the National Fibromyalgia Association and the British Fibromyalgia Syndrome Advisory Board. T. V. Sciarrillo, Chief Executive Officer Prior to joining Inmedix, Tim Sciarrillo’s distinguished career included over twenty years as a C-level executive in the medical, management consulting and real estate industries. He is also CEO of The New England Group, a management consulting firm founded by him in 1989. Tim’s professional experience includes many years at the accounting firm Deloitte and Touche as both an employee and a consultant to the C-level executives. He graduated from the College of the Holy Cross with a degree in Physics.
Dr. Patrick Wood, M.D. Assistant Professor of Family Medicine, Anesthesiology and Psychiatry Lynne Matallana Founder and President |
